The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.00
Bid: 61.00
Ask: 65.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.557%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: NetScientific Agrees EMV Capital Buy; Raises GBP2.3 Million

Wed, 05th Aug 2020 20:08

NetScientific PLC - healthcare IP commercialisation company - Agrees to buy EMV Capital, an investment services company which has interests in the industrial high-tech, energy, circular economy, smart city, transportation and healthcare sectors. Consideration for deal to be settled via issue of 3.5 million NetScientific shares, valuing EMV Capital at GBP3.4 million. Plans a 10-to-1 capital reorganisation and conditionally raises GBP2.3 million in a share placing priced at 65 pence each, after taking into account the share consolidation.

Current stock price: 8.00 pence

Year-to-date change: up 19%

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 May 2021 19:15

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

Read more
13 May 2021 19:15

IN BRIEF: NetScientific's EMV advises on SageTech funding round

IN BRIEF: NetScientific's EMV advises on SageTech funding round

Read more
28 Apr 2021 14:04

TRADING UPDATES: Beximco's India jab mire; Lamprell gets Aramco deal

TRADING UPDATES: Beximco's India jab mire; Lamprell gets Aramco deal

Read more
31 Mar 2021 15:33

TRADING UPDATES: Aquis maiden full-year profit; Tern turns to profit

TRADING UPDATES: Aquis maiden full-year profit; Tern turns to profit

Read more
11 Mar 2021 19:10

IN BRIEF: NetScientific's vaccine consortium gains funding commitment

IN BRIEF: NetScientific's vaccine consortium gains funding commitment

Read more
23 Feb 2021 16:55

IN BRIEF: NetScientific Says Blanver Joins Covid Vaccine Consortium

IN BRIEF: NetScientific Says Blanver Joins Covid Vaccine Consortium

Read more
22 Feb 2021 09:30

NetScientific's ProAxsis Inks Licensing Deal With University Of Geneva

NetScientific's ProAxsis Inks Licensing Deal With University Of Geneva

Read more
3 Feb 2021 19:18

IN BRIEF: NetScientific Shares Restored After Drug Trial Announcement

IN BRIEF: NetScientific Shares Restored After Drug Trial Announcement

Read more
2 Feb 2021 14:21

IN BRIEF: NetScientific Shares Suspended Pending Notification

IN BRIEF: NetScientific Shares Suspended Pending Notification

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
11 Dec 2020 21:39

IN BRIEF: NetScientific's ProAxisis Wins Innovate UK Grant For Project

IN BRIEF: NetScientific's ProAxisis Wins Innovate UK Grant For Project

Read more
10 Dec 2020 15:35

NetScientific's ProAxsis gets grant for Covid-19 project

(Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent 'UKRI Ideas to Address Covid-19' competition.

Read more
30 Nov 2020 18:18

IN BRIEF: NetScientific Subsidiary Leads Financing Round In SageTech

IN BRIEF: NetScientific Subsidiary Leads Financing Round In SageTech

Read more
19 Nov 2020 20:21

IN BRIEF: NetScientific's ProAxsis Partners Up With DiaPharma

IN BRIEF: NetScientific's ProAxsis Partners Up With DiaPharma

Read more
19 Nov 2020 16:28

NetScientific's ProAxsis appoints North American distributor

(Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.